Ion Channels: New Actors Playing in Chemotherapeutic Resistance

In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or acquired drug resistance. Resistance to therapy is not only common, but expected: if systemic agents used for cancer treatment are usually active at the beginning of therapy (i.e., 90% of primary breas...

Full description

Bibliographic Details
Main Authors: Philippe Kischel, Alban Girault, Lise Rodat-Despoix, Mohamed Chamlali, Silviya Radoslavova, Hiba Abou Daya, Thibaut Lefebvre, Arthur Foulon, Pierre Rybarczyk, Frédéric Hague, Isabelle Dhennin-Duthille, Mathieu Gautier, Halima Ouadid-Ahidouch
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/11/3/376